Nevada Health Authority

Nevada Health Authority, a U.S. state government entity headquartered in Carson City, Nevada, receives federal grant funding as a recipient to deliver Medicaid expansion, rural health transformation, and developmental disability services and advocacy across Nevada. The organization operates exclusively as a prime grant recipient; the source identifies no federal contracts, IDVs, or subcontracting activity.

Nevada Health Authority's federal footprint concentrates entirely within the Department of Health and Human Services. The Centers for Medicare and Medicaid Services (CMS) anchors the dollar value with a five-year, $539.8 million Rural Health Transformation (RHT) Program cooperative agreement awarded December 29, 2025, running through October 30, 2030 (CFDA 93.798). This award funds four strategic initiatives: a $30 million Rural Health Outcomes Accelerator Program advancing value-based care, chronic disease management, and virtual care delivery in rural counties; a $40 million Flex Fund for Rural Providers modernizing healthcare infrastructure through medical technologies, equipment, mobile units, and emergency services; a Workforce Recruitment and Retention Program; and technology innovation initiatives. A second CMS cooperative agreement for $321,313.05 (CFDA 93.771, State Grants for the Implementation, Enhancement, and Expansion of Medicaid and CHIP School-Based Services) became effective May 1, 2026, through June 30, 2027, supporting expansion of school health services across Nevada's 18 local education agencies beyond students with individualized education programs.

The Administration on Aging funds Nevada Health Authority under the Developmental Disabilities Basic Support and Advocacy Grants program (CFDA 93.630) with a $654,542 formula grant running October 1, 2025, through September 30, 2027. The National Center for Chronic Disease Prevention and Health Promotion awarded a cooperative agreement for state promotion of strategies to advance oral health effective September 1, 2024, through August 31, 2027. Four of five awards reach completion within the next twenty-four months, exposing substantial recompete activity beginning in late 2026.